Search research articles
Contact Us
Filters
Showing results (31-40 of 65) with videos related to
Page
of 7
Sort By:
Acta Clinica Belgica
|
August 24, 2013
Unusual cause of severe anaemia in a patient with metastatic haemangiopericytoma
V Vanhaudenarde, L Duck, F Mazzeo, et al.
British Journal of Cancer
|
October 26, 2013
Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours
E Seront, R Boidot, C Bouzin, et al.
Head & Neck
|
June 20, 2012
Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: case report and review of the literature
I Sinapi, B Navez, M Hamoir, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2011
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study
C Villanueva, A Awada, M Campone, et al.
Cancer Research
|
April 28, 2001
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
J P Machiels, R T Reilly, L A Emens, et al.
Breast Cancer Research and Treatment
|
March 29, 2011
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
K Zaman, X Durando, J-F Baurain, et al.
Acta Clinica Belgica
|
May 13, 2009
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities
I Van Vlaenderen, J L Canon, V Cocquyt, et al.
Cancer Research
|
February 28, 2001
The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors
R T Reilly, J P Machiels, L A Emens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Acta Clinica Belgica
|
July 25, 2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium
N Cornelis, T Vermassen, D Schallier, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 65) with videos related to
Sort By:
Page
of 7
Acta Clinica Belgica
|
August 24, 2013
Unusual cause of severe anaemia in a patient with metastatic haemangiopericytoma
V Vanhaudenarde, L Duck, F Mazzeo, et al.
British Journal of Cancer
|
October 26, 2013
Tumour hypoxia determines the potential of combining mTOR and autophagy inhibitors to treat mammary tumours
E Seront, R Boidot, C Bouzin, et al.
Head & Neck
|
June 20, 2012
Seeding of the percutaneous endoscopic gastrostomy site from head and neck carcinoma: case report and review of the literature
I Sinapi, B Navez, M Hamoir, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2011
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study
C Villanueva, A Awada, M Campone, et al.
Cancer Research
|
April 28, 2001
Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice
J P Machiels, R T Reilly, L A Emens, et al.
Breast Cancer Research and Treatment
|
March 29, 2011
A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer
K Zaman, X Durando, J-F Baurain, et al.
Acta Clinica Belgica
|
May 13, 2009
Trastuzumab treatment of early stage breast cancer is cost-effective from the perspective of the Belgian health care authorities
I Van Vlaenderen, J L Canon, V Cocquyt, et al.
Cancer Research
|
February 28, 2001
The collaboration of both humoral and cellular HER-2/neu-targeted immune responses is required for the complete eradication of HER-2/neu-expressing tumors
R T Reilly, J P Machiels, L A Emens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 12, 2012
Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02)
S Schmitz, M-C Kaminsky-Forrett, S Henry, et al.
Acta Clinica Belgica
|
July 25, 2014
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium
N Cornelis, T Vermassen, D Schallier, et al.
Page
of 7